1,4-Bis(5-(trifluoromethyl)pyridin-2-yl)piperazine

Catalog No.: 
ACMZZT737
CAS No.: 
131136-84-0
Molecular Formula: 
C16H14F6N4
Molecular Weight: 
376.30
1,4-Bis(5-(trifluoromethyl)pyridin-2-yl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$121.00InquiryInquiry
10mg98%$148.00InquiryInquiry
50mg98%$209.00InquiryInquiry
100mg98%$276.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,4-Bis(5-(trifluoromethyl)pyridin-2-yl)piperazine
IUPAC Name1,4-bis(5-(trifluoromethyl)pyridin-2-yl)piperazine
Molecular FormulaC16H14F6N4
Molecular Weight376.30
SMILESFC(C1=CN=C(N2CCN(C3=NC=C(C(F)(F)F)C=C3)CC2)C=C1)(F)F
InChI KeyNWJPVXBIUDRQLH-UHFFFAOYSA-N
Synonym1,4-bis[5-(trifluoromethyl)pyridin-2-yl]piperazine;1,4-BIS(5-(TRIFLUOROMETHYL)-2-PYRIDYL)PIPERAZINE;Piperazine, 1,4-bis[5-(trifluoromethyl)-2-pyridinyl]-
CAS No.131136-84-0

Synthetic Route by SureRoute

1. ACMZZT737 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCPHV394 route compound structure diagram
    ACCPHV39450488-42-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMZZT737 route product structure diagram
    ACMZZT737131136-84-0
Inquiry

2. ACMZZT737 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAMEO124 route compound structure diagram
    ACAMEO124100366-75-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMZZT737 route product structure diagram
    ACMZZT737131136-84-0
Inquiry

3. ACMZZT737 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPVGH896 route compound structure diagram
    ACPVGH89633252-63-0In Stock
  4. Then
  5. ACMZZT737 route product structure diagram
    ACMZZT737131136-84-0
Inquiry

Comments (0)